|Year : 2022 | Volume
| Issue : 4 | Page : 89-95
Risk of sudden cardiac death and preventive measures in athletes
Adel Khalifa Sultan Hamad
Department of Electrophysiology, Mohammed Bin Khalifa Bin Salman Al Khalifa Cardiac Centre, Awali, Bahrain
|Date of Submission||07-Aug-2022|
|Date of Decision||05-Oct-2022|
|Date of Acceptance||12-Oct-2022|
|Date of Web Publication||29-Nov-2022|
Dr. Adel Khalifa Sultan Hamad
Department of Electrophysiology, Mohammed Bin Khalifa Bin Salman Al Khalifa Cardiac Centre, Awali
Source of Support: None, Conflict of Interest: None
Arrhythmias, which are fatal in some patients, can be triggered by sports in vulnerable people. It is estimated that 1:40,000–1:250,000 athletes will suffer a sudden cardiac death (SCD). However, female athletes appear to have some level of cardiac protection, since suffering from SCD considerably less than male athletes during sports. Athletes with underlying coronary, valvular or myocardial disease, as well as channelopathies, may be particularly prone to SCD from exercise- and sports-related physical activity. There are three main causes of SCD in young athletes: Sudden Arrhythmic Death Syndrome (56%), congenital anomalous coronary arteries (7%–14%), and hypertrophic cardiomyopathy (36%–48%). In the context of exercise, acute ischemia, myocardial infarction, and stroke risk are increased by catecholamine surge and exercise-induced stress. In middle-aged athletes, excessive cardiovascular activity is associated with a higher risk of mortality related to cardiovascular disease. It is possible to detect at-risk athletes by conducting cardiac screening, which involves a family history, physical examination, and a resting electrocardiogram. Consequently, efforts have been made to better understand the causes of SCD in athletes and to develop appropriate prevention methods.
Keywords: Athlete's heart, cardiac screening, cardiovascular abnormalities, sports, sudden cardiac death
|How to cite this article:|
Hamad AK. Risk of sudden cardiac death and preventive measures in athletes. Int J Cardiovasc Acad 2022;8:89-95
| Introduction|| |
The sudden cardiac death (SCD) rate among athletes is considerably lower than that of the general population. The public's response to SCD occurring during a sports event raises questions about cardiovascular risks related to sports. In this paper, we examine the pathophysiology and etiology of SCD among athletes engaged in sports and exercise. Numerous studies have found that regular exercise lowers cardiovascular mortality, including SCD significantly compared with sedentary lifestyles., In contrast, exercise- and sports-related physical activity have been linked to SCD, particularly in athletes with underlying coronary, valvular, myocardial disease, and channelopathies. It appears that exercise may exacerbate predisposed individuals' tendency to develop malignant arrhythmias. There has been extensive research conducted by sports cardiologists worldwide to quantify the incidence of SCD in athletes, identify risk factors, develop preparticipation screening tools, and formulate plans for on-field SCD management. The aim of this review is to inform the community about the current state of knowledge regarding athletes who are at risk of SCD.
| Epidemiology of Sudden Cardiac Death in Athletes|| |
Across studies, the incidence of SCD in athletes ranges from 1:40,000 to 1:250,000, with this variance being driven by different methodologies, demographics, and sports disciplines. A 5-year prospective study found that 4.6 people/1 million had sports-related SCD, compared with 50–100 people per million in the general population. Sudden death is influenced by several factors, including an athlete's age, race, gender, ethnicity, training level, and type of sport. Over 80% of sports-related SCD deaths occurred in adults aged 35 and older due to atherosclerotic coronary artery disease (CAD). While preparing for any sporting event, the risk of sudden cardiac arrest (SCA) or SCD is approximately five-fold higher. A higher rate of adverse events is observed in occasional runners (1/7500–18000) than in marathon runners (1/50,000–200,000). Sports competition has been associated with SCD in vulnerable individuals who experience lethal arrhythmias. Unlike male athletes, female athletes appear to have some level of cardiovascular protection, since they typically do not die suddenly during sports. According to the data from the United States, black athletes are at a higher risk of SCD than white athletes., Corrado et al., published one of the first large-scale studies of SCD in athletes in the Veneto area of Italy, which prospectively examined SCD events in a youth population (between 12 and 35 years of age), demonstrating an incidence rate equal to 1.0 in 100,000 people per year, including 2.3/100,000 among competitive athletes. The findings of Alattar et al. indicate that five (2.17%) Arab athletes had an SCD-related anomaly. Two of the athletes had Wolff-Parkinson-White (WPW) syndrome, one had Atrial Fibrillation, one had Long QT syndrome (LQTS), and one had arrhythmogenic right ventricular cardiomyopathy (ARVC). According to Riding et al., 10 athletes (0.47%) have pathological substrate related to SCD. The hypertrophic cardiomyopathy (HCM) syndrome was detected in five black athletes and two Arab athletes, while the WPW syndrome was detected in three Arab athletes. Among younger athletes, more than half of all deaths result from nonmedical or traumatic causes. It is estimated that 0.2%–0.7% of young athletes develop cardiovascular disorders predisposing to SCD during sports. Sudden arrhythmic death syndrome-SADS (56%), HCM (36%–48%), and congenital anomalous coronary arteries originating from opposing sinuses (14%–17%) are the most common causes of SCD in athletes, while ARVC (4%–11%), myocarditis (6%–7%), and ion channelopathies (4%), are the least common. SADS is an unexplained or unexpected sudden death especially in young, despite a comprehensive autopsy and toxicological analysis. SADS may be caused by underlying primary electric disease.Atherosclerotic CAD is the cause of only 2%–3% of SCD in younger athletes [Figure 1].
| Etiology|| |
A physical exertion-induced SCD can be deadly despite its rarity. A significant percentage of these deaths, even among young, seemingly healthy individuals, is caused by undiagnosed cardiovascular disease. Recent studies found that around 65% of sudden deaths in student-athletes did not involve cardiovascular causes, but rather a suicide, trauma, or substance abuse. A substantial number of sudden deaths were caused by drowning and heat strokes. [Table 1] and [Table 2] illustrate the pathological assessment and underlying conditions of SCD patients., More than three-quarters of nontraumatic sudden deaths in sports are caused by cardiovascular diseases. The cause of SCD in young athletes (<35 years old) can range from hereditary, congenital, or acquired structural and electrical problems. In the United States, SCD is most commonly caused by HCM, whereas in Italy, ARVC is commonly reported. Further causes of SCD include myocarditis, coronary artery abnormalities, valvular heart diseases, aortic dissection, commotio cordis, and inherited channelopathies such as WPW syndrome, LQTS, and Brugada syndrome. Children without obvious structural heart disease are also at risk of SCD, which occurs in as many as 12% of cases., It appears that these cases are associated with inherited arrhythmic substrates, and genetic testing of survivors of SCD might provide relevant results that explain the incident and may be valuable for family screening. Exercise-related SCD is also caused by drug use. For instance, cocaine and amphetamines can lead to myocardial infarction (MI), arrhythmias, myocarditis, and premature CAD. Chronic use of drugs can cause dilated cardiomyopathy, and performance-enhancing medications can have immediate negative effects on the cardiovascular system. Athletes who use anabolic drugs may be predisposed to hypertension, dyslipidemia, ventricular hypertrophy and fibrosis, and arrhythmias because of their ability to push themselves beyond their natural limits. Previously reported higher target hemoglobin levels with erythropoietin therapy are associated with an increased risk of MI or stroke [Table 3]. More than 85% of deaths among athletes over the age of 35 years are caused by atherosclerotic CAD [Figure 2]. In young athletes, congenital coronary artery abnormalities are a significant cause of death, particularly when they occur in the left coronary artery, which arises from the right sinus of the Valsalva and travels between the aorta and the pulmonary artery. It is possible for athletes to develop SCD due to mitral valve prolapse, bicuspid aortic valves, and aortopathies. There is a 0.5%–4% frequency of myocarditis in the general population; however, it may contribute to up to 22% of SCD in those under 35 years old. Myocarditis produces myocardial necrosis and fibrosis, which increases the risk of SCD by predisposing to life-threatening ventricular arrhythmias, and physical activity increases this risk. It is possible that persistent scarring after the acute phase of myocarditis increases the risk of developing arrhythmias and SCD. There is evidence that more than 40% of SCD patients may have a healthy heart, according to a large autopsy investigation at an expert cardiac pathology center in the UK. There is a small possibility that some patients have inherited channelopathies, such as WPW syndrome. There is growing evidence that structurally normal hearts are more prevalent than cardiomyopathy, which has led to a significant paradigm shift regarding SCD's etiology. Several studies have shown that senior male athletes who have exercised vigorously for most of their lives may develop cardiovascular problems such as coronary artery calcification, atrial fibrillation, and myocardial fibrosis.,, It is believed that these anomalies are probable consequences of exercise, and they were found in just a small proportion of female athletes. In spite of the fact that veteran male athletes had a higher frequency of coronary artery calcium than their sedentary counterparts, no differences were found between female athletes and controls. There has also been a report of myocardial fibrosis in experienced male athletes, but not in women. A recent study found that 17% of male triathletes exhibited late gadolinium enhancement in cardiac magnetic resonance but none of the female triathletes did. The RACE Paris registry showed that SCDs caused by CAD have an acute thrombotic occlusion, while the RACER registry of 10 million runners showed that SCDs are caused by fixed coronary stenosis without thrombosis. Therefore, there are two plausible causes for the occurrence of ventricular tachyarrhythmias and cardiac arrests during sports activities. In this condition, coronary flow cannot be increased during exercise due to tachycardia reducing diastolic duration and exhausting the coronary vasodilatory reserve beyond stenosis. A sudden discontinuance of activity can aggravate ischemia, as it reduces venous return and lowers blood pressure in a vasodilated state, eventually leading to coronary hypoperfusion. Acute ischemia is exacerbated by electrolyte imbalance, heat stroke, and an excess of catecholamines in the blood. Eventually, this leads to malignant ventricular arrhythmias, which can occur during or soon after endurance exercise. The second explanation is acute plaque rupture during exercise, increased wall shear strain on the fragile plaque, along with catecholamine-induced coronary spasm and endothelial dysfunction, induces erosion of the thin fibrous cap, as well as intra-plaque hemorrhage and thrombosis.
| Relation between Exercise, Cardiac Disease, and Sudden Cardiac Arrest|| |
In people with HCM, the balance between risk and benefit is unclear, with risks at extremely high levels of exercise., Researchers recently concluded that moderate-intensity exercise is safe and beneficial for people with HCM who are asymptomatic. With chronic diseases such as hypertension, a coronary disease with MI, and diabetes, regular exercise minimizes unfavorable cardiac remodeling. Heart failure, hypertension, and previous MI patients have been found to benefit from high-intensity interval training. Even high-intensity exercise poses virtually no risk to an athlete without predisposing factors or underlying cardiovascular disease. Sports and exercise offer a number of health benefits, including reduced mortality and morbidity risks as well as psychological benefits for the individual [Figure 3]., In the absence of cardiac disease, long-term endurance athletes who run 15–30 h per week have an increased risk of developing lone paroxysmal atrial fibrillation. In a recent meta-analysis, athletes had a higher chance of developing lone paroxysmal atrial fibrillation than sedentary individuals. In contrast, athletes with atrial fibrillation were less likely to suffer a stroke than their age-matched peers., The higher risk can be attributed to increased myocardial oxygen demand and adrenergic output, which can lead to an arrhythmogenic condition or ischemia. The prevalence of cardiac anomalies requiring further testing in sports has been found to be between 2% and 4%, with clinically significant abnormalities occurring in about 0.3% of athletes. According to experts, many disorders that could cause SCA in athletes, such as inherited channelopathies, an abnormal origin of the coronary arteries, and premature CAD, would not be detected on a normal electrocardiogram (ECG). ECG of children and adolescents with cardiomyopathies shows that it is less sensitive than previously thought to identify cardiomyopathies. Typical abnormalities are found only in 25%–75% of adolescents with ARVC and in 50%–75% of asymptomatic young patients with HCM. A recent longitudinal study of top soccer players discovered that 6 of every 8 SCDs (6/100,000/year) occurred in athletes with a negative history, physical examination, and ECG.
| Hearts of Athletes|| |
The cardiovascular systems of athletes and the general population differ in terms of their functional and structural characteristics because of the type of exercise they engage in. Swimming and long-distance running belong to the endurance training category, while wrestling, weightlifting, and sports belong to the strength training category. Cardiovascular fitness affects the heart in a unique way for each athlete. As a result of exercise, around half of all athletes will show cardiac remodeling. Among the changes are increased cavity sizes on the ventricles and left atrium. In endurance athletes, the left ventricular (LV) chamber may expand significantly, resulting in a moderate increase in absolute LV wall thickness. Athletes with high levels of training are also more likely to develop left atrial remodeling. During the acute phase of endurance exercise, oxygen consumption, cardiac output, stroke volume, and systolic blood pressure increase, while peripheral vascular resistance decreases. As a result of volume overload, endurance exercise leads to the dilation of the left ventricle, whereas resistance training leads to hypertrophy of the left ventricle. The risk of acute ischemia, MI, and SCD is higher during and up to 1 h after exercise when compared with sedentary hours. Compared to resting hours, exercise increases the risk of SCD by 8–16 times and MI by 6–10 times. As a result of regular and habitual physical activity, the greater relative risk associated with SCD, and acute MI is reduced.
| Screening Requirement|| |
In seemingly fit athletes, SCD usually occurs without warning symptoms or a history of heart disease. Sport-related sudden mortality can be reduced through preparticipation screening for silent cardiac conditions. The European Society of Cardiology (ESC), the American Heart Association (AHA), the International Olympic Committee (IOC), and the Federation Internationale de Football Association have endorsed preparticipation screening (PPS) cardiovascular for young athletes. It involves systematically evaluating athletes before competition to detect existing cardiac diseases that may put an athlete at risk for SCA, as well as other critical health issues. A screening program aims to detect athletes who are at high risk for sudden death and to restrict their participation in competitive or high-intensity activities to significantly reduce their risk. An examination and history of 14 points are part of the guidelines developed by the AHA for the PPS of competitive athletes. During a 25-year Italian preparticipation screening program, 0.2% of athletes had a disease that led to SCD based on their medical history, physical examination, 12-lead ECG, and restricted exercise testing. As a result of the screening process, the SCD rate dropped by 90% from 3.6/100,000 person-years to 0.4/100,000 person-years, with a false-positive rate of 7%.
| Preventive Measures and the Best Approach to Screen Athletes in a Primary Care Setting|| |
The assessment is primarily intended to improve athletes' health and safety. While preparticipation evaluations cannot prevent morbidity and death in sports, they can aid in the discovery of serious issues and the development of injury prevention strategies., All ages can benefit from sports and athletics, as it improves fitness, self-esteem, and coordination, and give athletes the opportunity for creative cooperation and competition. Any sport or level of competition will be open to athletes if their clearance status has been determined following appropriate tests, treatment, or rehabilitation. According to most guidelines, clinical history, physical examination, and ECG are the least expensive methods of preparticipation screening. In 2014, the AHA developed a 14-item cardiovascular screening checklist for congenital and hereditary heart disease in young athletes. A pre-participation evaluation (PPE) aims to ensure the athlete's health and safety during training and competition. Physicians will use this information to make decisions about an athlete's physical activity. Any positive reaction on any of the 14 items may be deemed sufficient by the examiner to begin a detailed cardiovascular investigation that may include an ECG, echocardiography, or stress test. The Canadian Cardiovascular Society and Canadian Heart Rhythm Society recently published a joint position statement on cardiovascular screening of competitive athletes recommending measuring and comparing blood pressure in both arms, auscultating for heart murmurs, and examining for features of Marfan syndrome. Even though first affirmative responses on the PPE form are intended to be examined by a physician before an additional examination, Fudge et al. discovered that 46% of the first affirmative responses still needed further investigation after having been reviewed by the physician. ECG screening improves sensitivity by identifying athletes with hereditary ion channel disease including accessory pathways, as well as raising suspicions of athletes with cardiomyopathy. An ECG is considered to be more sensitive than a history and physical exam in detecting underlying cardiovascular abnormalities that may place athletes at risk for SCD. In a prospective study, resting ECGs have not been added to screening protocols. As of yet, there is no mandate regarding ECG screening for collegiate athletes in the US, although the ESC and IOC recommends its use, whereas the AHA recommends only a history and physical examination, primarily due to the cost and infrastructure concerns. Cardiopulmonary resuscitation (CPR) and rapid defibrillation double the survival rate of sports-related SCD.,, The first responders should be trained in recognizing symptoms, activating the emergency medical system, performing CPR, and using an automated external defibrillator (AED). Before 1995, one SCD per 55,000 finishers occurred in US Marathons, but after 1995, it decreased to one per 220,000 finishers due to emergency medical response services. An athlete experiencing cardiac arrest can be efficiently revived by performing rapid CPR and using an AED in time. In a study by Weisfeldt et al., rapid use of an AED is associated with a higher chance of survival (odds ratio: 1.75; 95% confidence interval: 1.23–2.50; P = 0.002), with rates of survival to hospital discharge highest in recreational areas (49%). AED availability during a sporting event, education of trainers and bystanders, and systematic emergency response methods all contribute to high survival rates in settings with systematic emergency response methods and timely deployment of AEDs,,, [Table 4] and [Table 5].
|Table 5: Advantages and disadvantages of preparticipation sudden cardiac death screening|
Click here to view
| Conclusion|| |
Sudden cardiac mortality among sportsmen is relatively rare. Globally, cardiomyopathy, hypertrophic, and ARVC are the most common causes. SCD in sports might be avoided and reduced if we understand the origins and processes of such incidents. The PPS of athletes should include a history, physical examination, and ECG to identify those at high risk for SCD. As well as the role of paramedics/relevant stakeholders in aiding this process, appropriate PPS is essential to prevent SCD. There is a need for more research to develop solutions that can reduce the burden of SCD on this population.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al
. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002;347:1483-92.
Williams PT. Attenuating effect of vigorous physical activity on the risk for inherited obesity: A study of 47,691 runners. PLoS One 2012;7:e31436.
Emery MS, Kovacs RJ. Sudden cardiac death in athletes. JACC Heart Fail 2018;6:30-40.
Mannakkara NN, Sharma S. Sudden cardiac death in athletes. Trends Urol Mens Health 2020;11:10-4a.
Chugh SS, Weiss JB. Sudden cardiac death in the older athlete. J Am Coll Cardiol 2015;65:493-502.
Chomistek AK, Cook NR, Flint AJ, Rimm EB. Vigorous-intensity leisure-time physical activity and risk of major chronic disease in men. Med Sci Sports Exerc 2012;44:1898-905.
Vora A, Burkule N, Contractor A, Bhargava K. Prevention of sudden cardiac death in athletes, sportspersons and marathoners in India. Indian Heart J 2018;70:137-45.
Gerardin B, Collet JP, Mustafic H, Bellemain-Appaix A, Benamer H, Monsegu J, et al
. Registry on acute cardiovascular events during endurance running races: The prospective RACE Paris registry. Eur Heart J 2016;37:2531-41.
Harmon KG, Drezner JA, Wilson MG, Sharma S. Incidence of sudden cardiac death in athletes: A state-of-the-art review. Heart 2014;100:1227-34.
Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42:1959-63.
Alattar A, Ghani S, Mahdy N, Hussain H, Maffulli N. Pre-participation musculoskeletal and cardiac screening of male athletes in the United arab emirates. Transl Med UniSa 2014;9:43-9.
Riding NR, Sheikh N, Adamuz C, Watt V, Farooq A, Whyte GP, et al
. Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes. Heart 2015;101:384-90.
Mellor G, Raju H, de Noronha SV, Papadakis M, Sharma S, Behr ER, et al
. Clinical characteristics and circumstances of death in the sudden arrhythmic death syndrome. Circ Arrhythm Electrophysiol 2014;7:1078-83.
Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014;63:1636-43.
Wasfy MM, Hutter AM, Weiner RB. Sudden cardiac death in athletes. Methodist Debakey Cardiovasc J 2016;12:76-80.
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al
. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-90.
Kim ST, Park T. Acute and chronic effects of cocaine on cardiovascular health. Int J Mol Sci 2019;20:E584.
La Gerche A, Brosnan MJ. Cardiovascular effects of performance-enhancing drugs. Circulation 2017;135:89-99.
Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res 2015;116:1887-906.
Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al
. Etiology of sudden death in sports: Insights from a United Kingdom regional registry. J Am Coll Cardiol 2016;67:2108-15.
Semsarian C, Ingles J, Wilde AA. Sudden cardiac death in the young: The molecular autopsy and a practical approach to surviving relatives. Eur Heart J 2015;36:1290-6.
Merghani A, Maestrini V, Rosmini S, Cox AT, Dhutia H, Bastiaenan R, et al
. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation 2017;136:126-37.
Roberts WO, Schwartz RS, Kraus SM, Schwartz JG, Peichel G, Garberich RF, et al
. Long-Term marathon running is associated with low coronary plaque formation in women. Med Sci Sports Exerc 2017;49:641-5.
Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 2009;11:1156-9.25.
Tahir E, Starekova J, Muellerleile K, von Stritzky A, Münch J, Avanesov M, et al
. Myocardial fibrosis in competitive triathletes detected by contrast-enhanced CMR correlates with exercise-induced hypertension and competition history. JACC Cardiovasc Imaging 2018;11:1260-70.
Landry CH, Allan KS, Connelly KA, Cunningham K, Morrison LJ, Dorian P, et al
. Sudden cardiac arrest during participation in competitive sports. N Engl J Med 2017;377:1943-53.
Mohananey D, Masri A, Desai RM, Dalal S, Phelan D, Kanj M, et al
. Global incidence of sports-related sudden cardiac death. J Am Coll Cardiol 2017;69:2672-3.
Dias KA, Link MS, Levine BD. Exercise training for patients with hypertrophic cardiomyopathy: JACC review topic of the week. J Am Coll Cardiol 2018;72:1157-65.
Ambrosio L, Lambrick D, Faulkner J, Portillo MC. Accessibility and applicability of physical activity guidelines and recommendations for adults living with long term conditions during COVID-19. Int J Environ Health Res 2022;32:1-17.
Klempfner R, Kamerman T, Schwammenthal E, Nahshon A, Hay I, Goldenberg I, et al
. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: Results of a structured exercise training program in a cardiac rehabilitation center. Eur J Prev Cardiol 2015;22:13-9.
Ross LM, Porter RR, Durstine JL. High-intensity interval training (HIIT) for patients with chronic diseases. J Sport Health Sci 2016;5:139-44.
Kettunen JA, Kujala UM, Kaprio J, Bäckmand H, Peltonen M, Eriksson JG, et al
. All-cause and disease-specific mortality among male, former elite athletes: An average 50-year follow-up. Br J Sports Med 2015;49:893-7.
Lemez S, Baker J. Do elite athletes live longer? A systematic review of mortality and longevity in elite athletes. Sports Med Open 2015;1:16.
Ayinde H, Schweizer ML, Crabb V, Ayinde A, Abugroun A, Hopson J. Age modifies the risk of atrial fibrillation among athletes: A systematic literature review and meta-analysis. Int J Cardiol Heart Vasc 2018;18:25-9.
Hållmarker U, Åsberg S, Michaëlsson K, Ärnlöv J, Hellberg D, Lindbäck J, et al.
Risk of Recurrent Stroke and Death After First Stroke in Long-Distance Ski Race Participants. J Am Heart Assoc 2015;4:e002469.
Goodman JM, Burr JF, Banks L, Thomas SG. The acute risks of exercise in apparently healthy adults and relevance for prevention of cardiovascular events. Can J Cardiol 2016;32:523-32.
Risgaard B, Winkel BG, Jabbari R, Glinge C, Ingemann-Hansen O, Thomsen JL, et al
. Sports-related sudden cardiac death in a competitive and a noncompetitive athlete population aged 12 to 49 years: Data from an unselected nationwide study in Denmark. Heart Rhythm 2014;11:1673-81.
Malhotra A, Dhutia H, Finocchiaro G, Gati S, Beasley I, Clift P, et al
. Outcomes of cardiac screening in adolescent soccer players. N Engl J Med 2018;379:524-34.
Schmehil C, Malhotra D, Patel DR. Cardiac screening to prevent sudden death in young athletes. Transl Pediatr 2017;6:199-206.
Williams EA, Pelto HF, Toresdahl BG, Prutkin JM, Owens DS, Salerno JC, et al.
Performance of the American heart association (AHA) 14-point evaluation versus electrocardiography for the cardiovascular screening of high school athletes: A prospective study. J Am Heart Assoc 2019;8:e012235.
Arbab-Zadeh A, Perhonen M, Howden E, Peshock RM, Zhang R, Adams-Huet B, et al
. Cardiac remodeling in response to 1 year of intensive endurance training. Circulation 2014;130:2152-61.
Fudge J, Harmon KG, Owens DS, Prutkin JM, Salerno JC, Asif IM, et al
. Cardiovascular screening in adolescents and young adults: A prospective study comparing the pre-participation physical evaluation monograph 4th
Edition and ECG. Br J Sports Med 2014;48:1172-8.
Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: A systematic review/meta-analysis. J Electrocardiol 2015;48:329-38.
Marijon E, Bougouin W, Celermajer DS, Perier MC, Benameur N, Lamhaut L, et al
. Major regional disparities in outcomes after sudden cardiac arrest during sports. Eur Heart J 2013;34:3632-40.
Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 2005;46:1373-4.
Weisfeldt ML, Sitlani CM, Ornato JP, Rea T, Aufderheide TP, Davis D, et al
. Survival after application of automatic external defibrillators before arrival of the emergency medical system: Evaluation in the resuscitation outcomes consortium population of 21 million. J Am Coll Cardiol 2010;55:1713-20.
Aschieri D, Penela D, Pelizzoni V, Guerra F, Vermi AC, Rossi L, et al
. Outcomes after sudden cardiac arrest in sports centres with and without on-site external defibrillators. Heart 2018;104:1344-9.
Kinoshi T, Tanaka S, Sagisaka R, Hara T, Shirakawa T, Sone E, et al
. Mobile automated external defibrillator response system during road races. N Engl J Med 2018;379:488-9.
Dorian P, Goodman JM, Connelly KA. Policies to prevent sudden cardiac death in young athletes: Challenging, but more testing is not the answer. J Am Heart Assoc 2020;9:e016332.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]